Sudarshan Pharma Industries (SUDARSHAN) Share Price falls 10% to Rs 35.02
- October 8, 2026
- Posted by: Kunal Singla
- Category: News
Sudarshan Pharma Industries Share Price fell 10% to Rs 35.02, moving lower from the previous close of Rs 38.91. The company’s market capitalisation stood at Rs 962.41 Cr, placing it in the Micro Cap category. According to latest Univest figures, the decline is a clear price event for Sudarshan Pharma Industries Share Price today, even though no company-specific catalyst is established. For readers tracking Sudarshan Pharma Industries Share Price news, the move is relevant because it combines a sharp single-day fall with a valuation profile that still sits above the same-industry median on key ratios. The latest Univest figures also show a full-day range that began at Rs 39 and extended down to Rs 35.02, keeping Sudarshan Pharma Industries Share Price in focus for stock news, price action and fundamental analysis.
The price move is confirmed in Univest data; a company-specific reason has not been established.
Sudarshan Pharma Industries (SUDARSHAN) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 35.02 |
| Previous Close | Rs 38.91 |
| Today's Move | -Rs 3.89 (-10%) |
| Open | Rs 39 |
| High | Rs 39 |
| Low | Rs 35.02 |
| Market Capitalisation | Rs 962.41 crore |
| Market Cap Category | Micro Cap |
Sudarshan Pharma Industries Share Price today opened at Rs 39, matched the day high at Rs 39, and touched a low of Rs 35.02, which is also the last traded price in the live move. The stock declined Rs 3.89 from the previous close of Rs 38.91, reflecting a 10% fall in Sudarshan Pharma Industries Share Price during the current session. Market capitalisation at Rs 962.41 Cr keeps the company within the Micro Cap bracket, which is important context when reading Sudarshan Pharma Industries Share Price Live movement and Sudarshan Pharma Industries Share Price Update headlines. The gap between the opening level and the current price shows that the move developed after trade began rather than from a weak start. For Sudarshan Pharma Industries Share Price today, the key fact is simple: the stock is trading lower, and the price action remains the main driver of attention before any deeper Sudarshan Pharma Industries Stock Analysis.
For readers following Sudarshan Pharma Industries Share Price Today, the intraday pattern is straightforward. The stock has moved from Rs 39 to Rs 35.02, while the previous close stands at Rs 38.91. That combination makes the present Sudarshan Pharma Industries Share Price fall a one-session decline rather than a multi-session streak. The market cap also helps frame the move because a Micro Cap company can show sharper visible swings in Sudarshan Pharma Industries Share Price Live coverage than larger healthcare names. In short, the session’s range, the exact drop and the current price together define the story for Sudarshan Pharma Industries Share Price news. The next step is to see whether Sudarshan Pharma Industries Fundamental Analysis supports the current valuation.
Sudarshan Pharma Industries (SUDARSHAN) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 962.41 crore |
| P/E Ratio | 39.41x |
| P/B Ratio | 3.02x |
| ROE | 13.33% |
| ROCE | 14.42% |
| EPS | Rs 0.99 |
| Book Value Per Share | Rs 12.89 |
| Dividend Yield | 0% |
Sudarshan Pharma Industries (SUDARSHAN) fundamental metrics show P/E 39.41x, P/B 3.02x, ROE 13.33%, ROCE 14.42%. These ratios show where the company stands today and are not a call to buy or sell.
Sudarshan Pharma Industries has a market capitalisation of Rs 962.41 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 39.41x, P/B at 3.02x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 13.33% and ROCE of 14.42%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 0.99, book value per share of Rs 12.89, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.87x, median ROE of 11.61%, median ROCE of 13.46%. Together they describe the fundamental backdrop without implying a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 39.41x |
| Benchmark Median P/E | 31.87x |
| Benchmark Average P/E | 48.48x |
| Benchmark P/E Range | 3.58x to 708.87x |
| Company P/B Ratio | 3.02x |
| Benchmark Median P/B | 2.98x |
| Benchmark Average P/B | 4.31x |
| Company ROE | 13.33% |
| Benchmark Median ROE | 11.61% |
| Benchmark Average ROE | 10.59% |
| Company ROCE | 14.42% |
| Benchmark Median ROCE | 13.46% |
| Benchmark Average ROCE | 13.36% |
| Company Market Capitalisation | Rs 962.41 crore |
| Benchmark Median Market Cap | Rs 854.81 crore |
| Benchmark Average Market Cap | Rs 14,121.7 crore |
Sudarshan Pharma Industries (SUDARSHAN) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Sudarshan Pharma Industries (SUDARSHAN) has a P/E ratio of 39.41x, which is above the benchmark median of 31.87x, a difference of +23.66%. A P/E difference of this kind is a reference point rather than a recommendation.
Sudarshan Pharma Industries (SUDARSHAN) has a ROE of 13.33%, which is above the benchmark median of 11.61%, a difference of +14.81%. Sudarshan Pharma Industries (SUDARSHAN) has a ROCE of 14.42%, which is above the benchmark median of 13.46%, a difference of +7.13%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,32,120.23 | 35.37 | 4.95 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,53,389.76 | 86.95 | 14.4 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,81,739.76 | 82.14 | 19.96 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,15,710.44 | 25.51 | 4.27 | 19.69 | 21.39 |
| Laurus Labs | LAURUSLABS | 1,10,980.13 | 101.55 | 19.69 | 18.31 | 18.2 |
Sudarshan Pharma Industries (SUDARSHAN) has a P/E ratio of 39.41x compared with the displayed peer median of 82.14x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 13.33% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 14.42% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Sudarshan Pharma Industries (SUDARSHAN) has a market capitalisation of Rs 962.41 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Sudarshan Pharma Industries
- Sudarshan Pharma Industries Share Price fell 10% to Rs 35.02, making today’s price action the first point of attention.
- The company remains a Micro Cap with market capitalisation of Rs 962.41 Cr, which frames the scale of the move.
- P/E of 39.41 and P/B of 3.02 place Sudarshan Pharma Industries Share Price near the industry middle on valuation.
- ROE of 13.33% and ROCE of 14.42% sit above the same-industry medians, adding context for Sudarshan Pharma Industries Fundamental Analysis.
- Peer comparison shows a mixed position versus larger healthcare names such as Sun Pharmaceutical Industries, Zydus Lifesciences and Torrent Pharmaceuticals
About Sudarshan Pharma Industries
Sudarshan Pharma Industries operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is positioned as a Micro Cap with a market capitalisation of Rs 962.41 Cr, and its current market identity is best understood through the combination of price action and financial ratios rather than scale alone. Sudarshan Pharma Industries Share Price therefore reflects a business that is part of a highly benchmarked healthcare universe, where valuation, return on equity and return on capital employed are often compared closely with peers. For readers tracking Sudarshan Pharma Industries Company News, the business context is useful because it explains why the current Sudarshan Pharma Industries Share Price update is being read through both market movement and fundamentals.
Track Sudarshan Pharma Industries Share Price on Univest
Use Sudarshan Pharma Industries (SUDARSHAN) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
You can track Sudarshan Pharma Industries Share Price on Univest for live price movement, fundamental ratios, 52-week levels and market insights. Univest also helps readers compare Sudarshan Pharma Industries Stock News with sector context, peer valuations and company-level performance signals in one place. For anyone monitoring Sudarshan Pharma Industries Share Price Today, the platform keeps the latest numbers and analysis in a single view.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why did Sudarshan Pharma Industries Share Price fall today?
Ans. Sudarshan Pharma Industries Share Price fell 10% to Rs 35.02, but no company-specific catalyst is established. The verified facts show a sharp price event, a Rs 3.89 decline from the previous close and an intraday low of Rs 35.02.
What is the current Sudarshan Pharma Industries Share Price?
Ans. Sudarshan Pharma Industries Share Price was Rs 35.02 in the latest trade, compared with the previous close of Rs 38.91. The move places today’s decline at 10% and keeps the stock in focus for live price tracking.
What is Sudarshan Pharma Industries market capitalisation?
Ans. Sudarshan Pharma Industries Share Price is being tracked alongside a market capitalisation of Rs 962.41 Cr. That places the company in the Micro Cap category and slightly above the same-industry market-cap median of Rs 854.81 Cr.
Is Sudarshan Pharma Industries Share Price expensive or low-valued?
Ans. Sudarshan Pharma Industries Share Price trades at a P/E of 39.41 and P/B of 3.02. Against the same-industry medians of 31.87 and 2.98, the valuation sits near the middle rather than at an extreme.
How do Sudarshan Pharma Industries fundamentals look?
Ans. Sudarshan Pharma Industries Share Price is backed by ROE of 13.33% and ROCE of 14.42%, both above the same-industry medians. EPS is Rs 0.99 and book value is Rs 12.89 per share, while dividend yield is 0.
How does Sudarshan Pharma Industries compare with peers?
Ans. Sudarshan Pharma Industries Share Price sits below large healthcare names in market cap, including Sun Pharmaceutical Industries and Divi’s Laboratories On valuation, it is above some peers on P/E and below several on P/B.
What was the day’s trading range for Sudarshan Pharma Industries Share Price?
Ans. Sudarshan Pharma Industries Share Price opened at Rs 39, touched a high of Rs 39 and a low of Rs 35.02. The current price equals the day low, which helps define the intraday price action clearly.
What sector does Sudarshan Pharma Industries belong to?
Ans. Sudarshan Pharma Industries Share Price belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. The same-industry benchmark covers 199 companies, giving the stock a useful peer and valuation reference.
Should investors track Sudarshan Pharma Industries Share Price on Univest?
Ans. Sudarshan Pharma Industries Share Price can be tracked on Univest for live price movement, fundamental ratios and sector context. That makes it easier to compare today’s decline with valuation, peers and key financial metrics in one view.
